Open an account

NeuroSense Therapeutics

NRSNW · NASDAQ

$0.0075+$0.0008 (+11.94%)TodayMarket closed ·
No price history for this range.

NRSNW key statistics

Market cap
0
Price-earnings ratio
0.00
Dividend yield
—
Average volume
5.48K
Volume
5.41K
Open price
$0.0075
High today
$0.0075
Low today
$0.0075
52 Week high
$0.5445
52 Week low
$0.0011

NeuroSense Therapeutics (NRSNW) at a glance

As of Oct 23, 2026, NeuroSense Therapeutics (NRSNW) shares are priced at $0.0075, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Volume so far is 5.41K shares, in line with the average of 5.48K shares a day.

Over the past year NeuroSense Therapeutics has ranged from $0.0011 to $0.5445, and now sits 1% of the way up that range.

NRSNW news

  • Press releasePRNewswire

    NeuroSense Files U.S. Patent Application for Traumatic Brain Injury

  • Press releasePRNewswire

    NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones

  • Press releasePRNewswire

    NeuroSense Provides Update on Nasdaq Listing Compliance

  • Press releasePRNewswire

    NeuroSense Provides Business Update and Progress for the First Half of 2026

  • Press releasePRNewswire

    NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference

  • Press releasePRNewswire

    NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

  • Press releasePRNewswire

    NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"

  • Press releasePRNewswire

    NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.